Contributors
Article Sidebar
Main Article Content
Aaron Varghese, MD
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
Amma F. Agyemang, MD, PHD
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Annika M Bruger, PHD
TILS group, De Duve Institute, UCLouvain, Brussels, Belgium
Bárbara da Silva Martins
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil
Bawinile Hadebe, MD
Department of Nuclear Medicine, University of KwaZulu-Natal, Durban, South Africa
Diana Nunes, MSC
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal/Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal
Jean-Francois Baurain, MD, PHD
Gynaecological oncology board, Institut Roi Albert II, Cliniques universitaires Saint Luc, UCLouvain, Brussels, Belgium
Jean-Luc Squifflet, MD, PHD
Gynaecological oncology board, Institut Roi Albert II, Cliniques universitaires Saint Luc, UCLouvain, Brussels, Belgium
Josiany Carlos de Souza, MSC
Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil
Leticia Batista Azevedo Rangel, PHARMD, PHD
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil
Mariana Nunes, MSC
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal/Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal
Mariza Vorster, MD, PHD
Department of Nuclear Medicine, University of KwaZulu-Natal, Durban, South Africa
Mathieu Luyckx, MD
Gynaecological oncology board, Institut Roi Albert II, Cliniques universitaires Saint Luc, UCLouvain, Brussels, Belgium
Roberto Silva Ribeiro Junior
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil
Sara Ricardo, PHD
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal/Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal
Shashikant Lele, MD
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
Tatiana Massariol Pimenta
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil
Venesen Pillay, MD
Department of Nuclear Medicine, University of KwaZulu-Natal, Durban, South Africa
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.